The Pneumocystoscopic Transurethral Tumorresection using Photodynamic Diagnosis

Not Applicable

• Conditions: C53.9; C18.9; Cervix uteri, unspecified; C67.9; C20; Bladder, unspecified; Colon, unspecified; Malignant neoplasm of rectum

• Registration Number: DRKS00030549
• Lead Sponsor: Charité – Universitätsmedizin Berlin Klinik für Urologie Campus Benjamin Franklin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-05-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 215

Inclusion Criteria

Planned transurethral tumor resection

Exclusion Criteria

Allergy to hexaminolevulinate (Hevix) or indocyanine green (ICG); Planned open or laparoscopic tumor resection.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Recurrence rate in the first year

Secondary Outcome Measures

Name	Time	Method
Complication rate; surgery time